Nov 13, 2025 08:35AM Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy

Nov 6, 2025 08:45AM Entero subsidiary Grid AI signs letter of intent to integrate LV Grid team

Nov 6, 2025 08:45AM Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid

Oct 30, 2025 09:00AM Entero's Reinvention Gives the Grid, AI, and Investors Exactly What They're After: Power and Value (NASDAQ: ENTO)

Oct 30, 2025 06:01AM Entero regains NASDAQ compliance through Grid AI acquisition

Oct 30, 2025 06:00AM Entero Regains Nasdaq Compliance With Grid AI Acquisition

Oct 16, 2025 08:40AM Entero Therapeutics launches Grid AI Corp to manage data center power loads

Oct 16, 2025 08:40AM Entero Therapeutics, Inc., Launches Grid AI Corp to Redefine How AI Infrastructure Connects to the Power Grid

Oct 14, 2025 11:00AM Entero Therapeutics pivots from biotech to energy grid technology

Oct 14, 2025 11:00AM From Biotech to Grid Tech, Entero Therapeutics Enters a $2.5 Billion Market Expected to Quadruple by 2033 (NASDAQ:ENTO)

Oct 14, 2025 08:00AM Entero Therapeutics acquires GRID AI in strategic shift to energy sector

Oct 14, 2025 08:00AM Entero Therapeutics Steps Into the $2.5 Billion Grid-Edge Arena With Global-Scale Validation Behind It

Oct 1, 2025 04:06PM Entero Therapeutics acquires GRID AI to enter AI energy market

Oct 1, 2025 04:05PM ENTERO THERAPEUTICS (ENTO) Enters $100 Billion+ AI and Data Center Market with Acquisition of GRID AI

Oct 1, 2025 08:34AM Entero Therapeutics acquires GRID AI for grid-edge energy platform

Oct 1, 2025 08:30AM ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand

Sep 9, 2025 05:05PM Entero Therapeutics names new interim CEO after leadership change

Aug 14, 2025 09:17AM Entero Therapeutics announces 1-for-3 reverse stock split

Aug 14, 2025 09:15AM Entero Therapeutics, Inc. Announces Reverse Stock Split

Aug 11, 2025 07:32AM Entero Therapeutics raises $3 million in private placement

Aug 11, 2025 07:30AM Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules

Jun 23, 2025 04:09PM Entero Therapeutics (ENTO) Files for 12M Share and Warrant Offering

Jun 13, 2025 10:46AM FluroTech Ltd. Announces Change in Directors

Mar 24, 2025 10:51PM Entero Therapeutics Announces Signing of Rescission Agreement with ImmunogenX, LLC

Feb 14, 2025 04:01PM Entero Therapeutics (ENTO) Appoints Richard Paolone as CEO

Feb 7, 2025 03:26PM Entero Therapeutics (ENTO) Secures $2M Revolving Loan; Appoints Three New Board Members

Nov 13, 2024 07:00AM Entero Therapeutics (ENTO) Announces Proposed Reverse Merger with Journey Therapeutics

Sep 10, 2024 07:03AM Entero Therapeutics (ENTO) Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings